{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T10:48:30Z","timestamp":1793789310504,"version":"4.6.1"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T00:00:00Z","timestamp":1681171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Recent studies have reported that gut microbiota is closely associated with cognitive fuction. Fecal microbiota transplantation (FMT) may be a potential treatment for cognitive impairment, but its efficacy in patients with cognitive impairment is unknown.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>This study aimed to investigate the safety and efficacy of FMT for cognitive impairment treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Five patients aged 54\u201380 years (three women) were enrolled in this single-arm clinical trial from July 2021 to May 2022. The Montreal Cognitive Assessment-B (MoCA-B), Activities of Daily Living (ADL), and the cognitive section of the Alzheimer\u2019s Disease Assessment Scale (ADAS-Cog) were assessed at days 0, 30, 60, 90, and 180. Additionally, stool and serum samples were obtained twice before FMT was administered and six months after the treatment. The structure of fecal microbiota was analyzed by 16S RNA gene sequencing. Serum samples were analyzed for metabolomics and lipopolysaccharide (LPS)-binding proteins by liquid chromatography-mass spectrometry and enzyme-linked immunosorbent assay, respectively. Safety was assessed based on adverse events, vital signs, and laboratory parameters during FMT and the follow-up period.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The MoCA, ADL, and ADAS-Cog scores of patients with mild cognitive impairment (patients C and E) after FMT were improved or maintained compared with those before transplantation. However, patients with severe cognitive impairment (patients A, B, and D) had no worsening of cognitive scores. Fecal microbiota analysis showed that FMT changed the structure of gut microbiota. The results of serum metabolomics analysis suggested that there were significant changes in the serum metabolomics of patients after FMT, with 7 up-regulated and 28 down-regulated metabolites. 3b,12a-dihydroxy-5a-cholanoic acid, 25-acetylvulgaroside, deoxycholic acid, 2(R)-hydroxydocosanoic acid, and P-anisic acid increased, while bilirubin and other metabolites decreased. KEFF pathway analysis indicated that the main metabolic pathways were bile secretion and choline metabolism in cancer. No adverse effects were reported throughout the study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In this pilot study, FMT could maintain and improve cognitive function in mild cognitive impairment by changing gut microbiota structure and affecting serum metabolomics. Fecal bacteria capsules were safe. However, further studies are needed to evaluate the safety and efficacy of fecal microbiota transplantation. ClinicalTrials.gov Identifier: CHiCTR2100043548.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcimb.2023.1103189","type":"journal-article","created":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T10:01:42Z","timestamp":1681207302000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":50,"title":["Preliminary evidence for developing safe and efficient fecal microbiota transplantation as potential treatment for aged related cognitive impairments"],"prefix":"10.3389","volume":"13","author":[{"given":"Xiaoxia","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shufang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haihong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,4,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-019-1494-4","article-title":"Antibiotics, gut microbiota, and alzheimer\u2019s disease","volume":"16","author":"Angelucci","year":"2019","journal-title":"J. Neuroinflammation."},{"key":"B2","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.stem.2020.04.002","article-title":"FASN-dependent lipid metabolism links neurogenic Stem\/Progenitor cell activity to learning and memory deficits","volume":"27","author":"Bowers","year":"2020","journal-title":"Cell Stem Cell."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/nu12041173","article-title":"Lysophosphatidylcholine containing anisic acid is able to stimulate insulin secretion targeting G protein coupled receptors","volume":"12","author":"Drzazga","year":"2020","journal-title":"Nutrients"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e00051","DOI":"10.1128\/mSystems.00051-17","article-title":"Insights into butyrate production in a controlled fermentation system via gene predictions","volume":"2","author":"Esquivel-Elizondo","year":"2017","journal-title":"mSystems"},{"key":"B5","doi-asserted-by":"publisher","first-page":"285","DOI":"10.3322\/caac.21676","article-title":"Fecal microbiota transplants may aid melanoma immunotherapy resistance","volume":"71","author":"Fillon","year":"2021","journal-title":"CA-CANCER J. Clin."},{"key":"B6","doi-asserted-by":"publisher","first-page":"102502","DOI":"10.1016\/j.anaerobe.2021.102502","article-title":"Fecal microbiota transplantation as therapy for recurrent clostridioides difficile infection is associated with amelioration of delirium and accompanied by changes in fecal microbiota and the metabolome","volume":"73","author":"Gotoh","year":"2021","journal-title":"ANAEROBE"},{"key":"B7","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3233\/JAD-201040","article-title":"Gut microbiome features of Chinese patients newly diagnosed with alzheimer\u2019s disease or mild cognitive impairment","volume":"80","author":"Guo","year":"2021","journal-title":"J. Alzheimers Dis."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.14336\/AD.2020.0106","article-title":"Prebiotics regulation of intestinal microbiota attenuates cognitive dysfunction induced by surgery stimulation in APP\/PS1 mice","volume":"11","author":"Han","year":"2020","journal-title":"Aging Dis."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1177\/0300060520925930","article-title":"Rapid improvement in alzheimer\u2019s disease symptoms following fecal microbiota transplantation: a case report","volume":"48","author":"Hazan","year":"2020","journal-title":"J. Int. Med. Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12934-021-01705-0","article-title":"A comprehensive approach to stool donor screening for faecal microbiota transplantation in China","volume":"20","author":"He","year":"2021","journal-title":"Microb Cell Fact."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JAD-161141","article-title":"The gut microbiota and alzheimer\u2019s disease","volume":"58","author":"Jiang","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-017-00900-1","article-title":"The gut microbiome in atherosclerotic cardiovascular disease","volume":"8","author":"Jie","year":"2017","journal-title":"Nat. Commun."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-42183-0","article-title":"Long-term benefit of microbiota transfer therapy on autism symptoms and gut microbiota","volume":"9","author":"Kang","year":"2019","journal-title":"Sci. Rep."},{"key":"B14","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/s0197-4580(00)00128-7","article-title":"Increased bilirubins and their derivatives in cerebrospinal fluid in alzheimer\u2019s disease","volume":"21","author":"Kimpara","year":"2000","journal-title":"Neurobiol. AGING."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e2136008","DOI":"10.1001\/jamanetworkopen.2021.36008","article-title":"Association of l-\u03b1 glycerylphosphorylcholine with subsequent stroke risk after 10 years","volume":"4","author":"Lee","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-14676-4","article-title":"Gut microbiota mediates intermittent-fasting alleviation of diabetes-induced cognitive impairment","volume":"11","author":"Liu","year":"2020","journal-title":"Nat. Commun."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1093\/ajcn\/nqaa085","article-title":"Afternoon distraction: a high-saturated-fat meal and endotoxemia impact postmeal attention in a randomized crossover trial","volume":"111","author":"Madison","year":"2020","journal-title":"Am. J. Clin. Nutr."},{"key":"B18","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to alzheimer\u2019s disease: Recommendations from the national institute on aging-alzheimer\u2019s association workgroups on diagnostic guidelines for alzheimer's disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Demen."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1038\/s41591-021-01399-2","article-title":"Fecal microbial transplantation and fiber supplementation in patients with severe obesity and metabolic syndrome: a randomized double-blind, placebo-controlled phase 2 trial","volume":"27","author":"Mocanu","year":"2021","journal-title":"Nat. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/nutrit\/nuy009","article-title":"Relationship between the gut microbiome and brain function","volume":"76","author":"Mohajeri","year":"2018","journal-title":"Nutr. Rev."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.3233\/JAD-142925","article-title":"A blood-based, 7-metabolite signature for the early diagnosis of alzheimer's disease","volume":"45","author":"Olazar\u00e1n","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1021\/pr800667a","article-title":"Proteomics-determined differences in the concanavalin-a-fractionated proteome of hippocampus and inferior parietal lobule in subjects with alzheimer\u2019s disease and mild cognitive impairment: implications for progression of AD","volume":"8","author":"Owen","year":"2009","journal-title":"J. Proteome Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jalz.2012.11.007","article-title":"The global prevalence of dementia: a systematic review and metaanalysis","volume":"9","author":"Prince","year":"2013","journal-title":"Alzheimers Dement."},{"key":"B24","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/jcbfm.2015.164","article-title":"The neuropathology and cerebrovascular mechanisms of dementia","volume":"36","author":"Raz","year":"2016","journal-title":"J. Cereb Blood Flow Metab."},{"key":"B25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.4161\/gmic.22973","article-title":"The intestinal microbiome, probiotics and prebiotics in neurogastroenterology","volume":"4","author":"Saulnier","year":"2013","journal-title":"Gut Microbes"},{"key":"B26","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00253-016-8006-6","article-title":"Interaction of gut microbiota with bile acid metabolism and its influence on disease states","volume":"101","author":"Staley","year":"2017","journal-title":"Appl. Microbiol. BIOT."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer's disease","volume":"362","author":"Steel","year":"2010","journal-title":"N Engl. J. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-019-0525-3","article-title":"Fecal microbiota transplantation alleviated alzheimer\u2019s disease-like pathogenesis in APP\/PS1 transgenic mice","volume":"9","author":"Sun","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-022-02435-9","article-title":"Gut microbiota is causally associated with poststroke cognitive impairment through lipopolysaccharide and butyrate","volume":"19","author":"Wang","year":"2022","journal-title":"J. Neuroinflammation."},{"key":"B30","doi-asserted-by":"publisher","first-page":"535310","DOI":"10.1038\/s41598-021-97548-1","article-title":"Fecal and serum metabolomic signatures and microbial community profiling of postmenopausal osteoporosis mice model","volume":"10","author":"Wen","year":"2020","journal-title":"Sci. Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-97548-1","article-title":"Altered fecal microbiota composition in individuals who abuse methamphetamine","volume":"11","author":"Yang","year":"2021","journal-title":"Sci. Rep."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.18632\/aging.101978","article-title":"Abnormal gut microbiota composition contributes to cognitive dysfunction in streptozotocin-induced diabetic mice","volume":"11","author":"Yu","year":"2019","journal-title":"Aging (Albany NY)."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.18632\/aging.101464","article-title":"Abnormal gut microbiota composition contributes to cognitive dysfunction in SAMP8 mice","volume":"10","author":"Zhan","year":"2018","journal-title":"Aging (Albany NY)."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.3233\/JAD-170020","article-title":"Altered gut microbiota in a mouse model of alzheimer\u2019s disease","volume":"60","author":"Zhang","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e02159","DOI":"10.1128\/spectrum.02159-21","article-title":"A matching strategy to guide donor selection for ulcerative colitis in fecal microbiota transplantation: Meta-analysis and analytic hierarchy process","volume":"11","author":"Zhang","year":"2022","journal-title":"Microbiol Spectr."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2019.112371","article-title":"Integrated network pharmacology analysis and serum metabolomics to reveal the cognitive improvement effect of bushen tiansui formula on alzheimer's disease","volume":"249","author":"Zhang","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1093\/gbe\/evu211","article-title":"Phylogenomics and evolutionary dynamics of the family actinomycetaceae","volume":"6","author":"Zhao","year":"2014","journal-title":"Genome Biol. Evol."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2023.1103189\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T10:01:44Z","timestamp":1681207304000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2023.1103189\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,11]]},"references-count":37,"alternative-id":["10.3389\/fcimb.2023.1103189"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2023.1103189","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,11]]},"article-number":"1103189"}}